Literature DB >> 1351433

CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells.

W H Alwan1, F M Record, P J Openshaw.   

Abstract

Respiratory syncytial (RS) virus-specific T cell lines were derived from the spleens of BALB/c mice primed by intranasal infection with RS virus. The lines were expanded by repeated antigenic stimulation in vitro, and separated into CD4+ and CD8+ T cell-enriched fractions by immunomagnetic adhesion. The effects of passive transfer of these fractions into RS virus infected mice were observed. The most severe immunopathological changes were seen in mice receiving CD4+ cells. Transfer of CD4+, CD8+ or both cell fractions caused RS virus-infected mice to become ill and lose weight. Both cell lines caused an increase in the severity of lung pathology (as monitored by bronchoalveolar lavage) with the appearance of lung haemorrhage and polymorphonuclear cell efflux. In addition, recipients of CD4+ cells developed striking pulmonary eosinophilia. In CD4+ cell recipients, 5 x 10(5) cells were sufficient to decrease lung virus titre, whereas 2 x 10(6) CD8+ cells were needed to produce a similar effect. The unseparated T cell line and the CD4+ cell fraction secreted significant amounts of IL-3, IL-4 and IL-5 (P less than 0.001). High levels of IL-2 were produced only by the unseparated T cell line. The CD8+ cell fraction secreted IL-3 only. The results show that, cell-for-cell, CD4+ cells are more anti-viral and more immunopathogenic than CD8+ cells in RS virus infected mice. Such effects may have contributed to the augmented disease seen in some infants vaccinated against RS virus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351433      PMCID: PMC1554527          DOI: 10.1111/j.1365-2249.1992.tb06482.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.

Authors:  P J Openshaw; S L Clarke; F M Record
Journal:  Int Immunol       Date:  1992-04       Impact factor: 4.823

2.  Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice.

Authors:  M J Cannon
Journal:  J Virol Methods       Date:  1987-07       Impact factor: 2.014

3.  Pulmonary function abnormalities in symptom-free children after bronchiolitis.

Authors:  M Kattan; T G Keens; J G Lapierre; H Levison; A C Bryan; B J Reilly
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

4.  Dementia--the quiet epidemic.

Authors: 
Journal:  Br Med J       Date:  1978-01-07

5.  Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

Authors:  E J Stott; G Taylor; L A Ball; K Anderson; K K Young; A M King; G W Wertz
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness.

Authors:  W L Castleman; R L Sorkness; R F Lemanske; P K McAllister
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

7.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease.

Authors:  R C Welliver; A Kaul; P L Ogra
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

9.  Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.

Authors:  C Bogdan; K Schröppel; M Lohoff; M Röllinghoff; W Solbach
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

10.  Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells.

Authors:  M J Cannon; E J Stott; G Taylor; B A Askonas
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

View more
  57 in total

1.  HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.

Authors:  A H Brandenburg; L de Waal; H H Timmerman; P Hoogerhout; R L de Swart; A D Osterhaus
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Immunological responses to respiratory syncytial virus infection in infancy.

Authors:  R L Smyth; J N Fletcher; H M Thomas; C A Hart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

3.  Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves.

Authors:  R M Gaddum; R S Cook; L H Thomas; G Taylor
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.

Authors:  Matthew R Olson; Steven M Varga
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves.

Authors:  G Taylor; L H Thomas; S G Wyld; J Furze; P Sopp; C J Howard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Cell-mediated immune responses of lambs to challenge with bovine respiratory syncytial virus.

Authors:  A K Sharma; Z Woldehiwet
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro.

Authors:  Yusheng Li; Darrell L Dinwiddie; Kevin S Harrod; Yong Jiang; K Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-15       Impact factor: 5.464

8.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 9.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.

Authors:  John S Tregoning; Yuko Yamaguchi; James Harker; Belinda Wang; Peter J M Openshaw
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.